IDEXX Laboratories (IDXX) PT Raised to $160 at Piper Jaffray Following In-Line Q4; 'Neutral' Rating Maintained
Tweet Send to a Friend
Piper Jaffray analyst Kevin Ellich raised his price target on IDEXX Laboratories (NASDAQ: IDXX) to $160.00 (from $129.00) following mostly ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
